Back to search

Article

Mass spectrometry based immunopeptidomics leads to robust predictions of phosphorylated HLA class I ligands

2019-11-09

Abstract excerpt

The presentation of peptides on class I human leukocyte antigen (HLA-I) molecules plays a central role in immune recognition of infected or malignant cells. In cancer, non-self HLA-I ligands can arise from many different alterations, including non-synonymous mutations, gene fusion, cancer-specific alternative mRNA splicing or aberrant post-translational modifications. Identifying HLA-I ligands remains a challengin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1c99768c-7d2d-53ed-bf0a-5ee6f6de757f
DOI
10.1101/836189
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mass spectrometry based immunopeptidomics leads to robust predictions of phosphorylated HLA class I ligandsDOI 10.1101/836189
Select a neighboring publication to make it the new centre.